THE PROGNOSTIC-SIGNIFICANCE OF X-RAY CHANGES AT PRESENTATION AND REASSESSMENT IN PATIENTS WITH MULTIPLE-MYELOMA

被引：34

作者：

SMITH, DB

SCARFFE, JH

EDDLESTON, B

机构：

[1] CHRISTIE HOSP & HOLT RADIUM INST,CANC RES CAMPAIGN DEPT MED ONCOL,MANCHESTER M20 9BX,LANCS,ENGLAND

[2] CHRISTIE HOSP & HOLT RADIUM INST,DEPT DIAGNOST RADIOL,MANCHESTER M20 9BX,LANCS,ENGLAND

来源：

HEMATOLOGICAL ONCOLOGY | 1988年 / 6卷 / 01期

关键词：

D O I：

10.1002/hon.2900060102

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1 / 6

页数：6

共 13 条

[1]

DEGRAMONT A, 1985, SCAND J HAEMATOL, V34, P78

[2] RELATION OF OSTEOCLAST ACTIVATING FACTOR PRODUCTION TO EXTENT OF BONE-DISEASE IN MULTIPLE-MYELOMA [J].

DURIE, BGM ;

SALMON, SE ;

MUNDY, GR .

BRITISH JOURNAL OF HAEMATOLOGY, 1981, 47 (01) :21-30

[3]

DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO

[4]

2-U

[5]

GOMPELS BM, 1972, RADIOLOGY, V104, P509, DOI 10.1148/104.3.509

[6] VARIATIONS IN THE ROENTGEN APPEARANCE OF THE SKELETAL SYSTEM IN MYELOMA [J].

HEISER, S ;

SCHWARTZMAN, JJ .

RADIOLOGY, 1952, 58 (02) :178-191

[7] GROWTH RATES AND RESPONSES TO TREATMENT IN HUMAN MYELOMATOSIS [J].

HOBBS, JR .

BRITISH JOURNAL OF HAEMATOLOGY, 1969, 16 (06) :607-&

[8]

MERLINI G, 1980, BLOOD, V55, P1011

[9] DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .2. ANALYSIS AND EXAMPLES [J].

PETO, R ;

PIKE, MC ;

ARMITAGE, P ;

BRESLOW, NE ;

COX, DR ;

HOWARD, SV ;

MANTEL, N ;

MCPHERSON, K ;

PETO, J ;

SMITH, PG .

BRITISH JOURNAL OF CANCER, 1977, 35 (01) :1-39

[10]

ROBINSON EL, 1982, CLIN CHEM, V28, P2254

← 1 2 →